Myriad Genetics Inc
DUS:MYD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Myriad Genetics Inc
DUS:MYD
|
US |
|
G
|
GEA Group AG
XMUN:G1A
|
DE |
|
Lifecore Biomedical Inc
F:LDE
|
US |
|
R
|
Ramsay Health Care Ltd
F:RMY0
|
AU |
|
C
|
Carlisle Companies Inc
DUS:CLE
|
US |
|
S
|
Siemens AG
SWB:SIE
|
DE |
|
Antero Resources Corp
NYSE:AR
|
US |
|
F
|
Fanuc Corp
XMUN:FUC
|
JP |
Wall St Price Targets
MYD Price Targets Summary
Myriad Genetics Inc
According to Wall Street analysts, the average 1-year price target for MYD is 2.637 EUR with a low forecast of 1.632 EUR and a high forecast of 4.241 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MYD's stock price target?
Price Target
2.637
EUR
According to Wall Street analysts, the average 1-year price target for MYD is 2.637 EUR with a low forecast of 1.632 EUR and a high forecast of 4.241 EUR.
What is the Revenue forecast for Myriad Genetics Inc?
Projected CAGR
6%
Over the last 4 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 5 years is 6%.
What is the Gross Profit forecast for Myriad Genetics Inc?
Projected CAGR
8%
Over the last 4 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 4 years is 8%.